Skip to main content

Table 1 Demographic and clinical features

From: Metabolic risk factor profile associated with use of second generation antipsychotics: a cross sectional study in a community mental health centre

 

Reference

N = 36

Clozapine

N = 6

Risperidone

N = 20

Olanzapine

N = 31

Quetiapine

N = 19

Male

17(47.2%)

4 (67.0%)

13 (65.0%)

10 (32.3%)

11 (57.9%)

Age (years)*

37.3 ± 8.6

37.2 ± 4.0

41.4 ± 15.1

47.3 ± 17.8

45.9 ± 15.4

Psychiatric Diagnosis

Schizophrenia and other psychotic disorders

 

6 (100%)

15 (75%)

23 (74.2%)

10 (52.6%)

Affective disorders

 

0

5 (25%)

8 (25.8%)

9 (47.4%)

  1. *df 4(107), F = 2.64, p = 0.038